Drawing for MIXPRO

USPTO serial 79083318

MIXPRO

Reviewed by CopyMark Law Group

Reg. 3892895Status 706Registered
Filing date
Status date
Registration date
Dec 21, 2010
Examiner
MORENO, PAUL A
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with MIXPRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

Claudia A. Smith White & Case LLP1221 Avenue of the AmericasTrademark DepartmentNew York, NY 10020

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for haemostasis managementACTIVE—
010Medical devices for reconstituting pharmaceutical preparations for haemostasis managementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 6, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 8, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 8, 202171AGREGISTERED-SEC.71 ACCEPTED—
Jan 6, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 29, 2020ES71TEAS SECTION 71 RECEIVED—
May 21, 2020RNWLINTERNATIONAL REGISTRATION RENEWED—
Dec 21, 2019REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jan 23, 2018INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jan 9, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 9, 2017NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 9, 201771AGREGISTERED-SEC.71 ACCEPTED—
May 9, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 13, 2016ES71TEAS SECTION 71 RECEIVED—
Dec 21, 2015REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 5, 2015CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 30, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Nov 27, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 4, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 28, 2011GPNXNOTIFICATION PROCESSED BY IB—
Feb 9, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2011IRFIIRREGULARITY ON FINAL DECISION RECEIVED FROM IB—
Jan 20, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 20, 2011FIMPFINAL DISPOSITION PROCESSED—
Jan 20, 2011GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Dec 21, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2010NPUBNOTICE OF PUBLICATION—
Sep 1, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 1, 2010ALIEASSIGNED TO LIE—
Aug 18, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 17, 2010DOCKASSIGNED TO EXAMINER—
Jul 6, 2010MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 2, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 1, 2010REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance